Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,3
USD
|
-0,76%
|
|
-2,26%
|
-34,01%
|
Fiscaal tijdperk: december |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
450,3
|
96,44
|
95,07
|
62,74
|
-
|
-
|
Bedrijfswaarde
1 |
218,1
|
-60,5
|
95,07
|
62,74
|
62,74
|
62,74
|
K/w-verhouding
|
-10,3
x
|
-1,4
x
|
-1,21
x
|
-0,84
x
|
-0,86
x
|
-0,88
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
14,5
x
|
6,18
x
|
10,4
x
|
8,96
x
|
5,81
x
|
4,24
x
|
Bedrijfswaarde/omzet
|
14,5
x
|
6,18
x
|
10,4
x
|
8,96
x
|
5,81
x
|
4,24
x
|
Bedrijfswaarde/EBITDA
|
-13.403.315
x
|
-1.374.778
x
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-7,26
x
|
-1,28
x
|
-
|
-0,76
x
|
-0,68
x
|
-0,65
x
|
FCF Yield
|
-13,8%
|
-78,3%
|
-
|
-131%
|
-146%
|
-155%
|
Price to Book
|
1,42
x
|
0,54
x
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
35.907
|
36.257
|
48.258
|
48.258
|
-
|
-
|
Referentieprijs
2 |
12,54
|
2,660
|
1,970
|
1,300
|
1,300
|
1,300
|
Datum van publicatie
|
17-03-22
|
14-03-23
|
12-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
30,98
|
15,62
|
9,16
|
7
|
10,8
|
14,8
|
EBITDA
|
-44,56
|
-33,59
|
-70,15
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-44,52
|
-34,14
|
-70,9
|
-75,42
|
-79,78
|
-88,15
|
-93,42
|
Operationele Marge
|
-
|
-110,18%
|
-453,99%
|
-823,33%
|
-1.139,64%
|
-816,16%
|
-631,21%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-34,12
|
-68,76
|
-68,33
|
-76,59
|
-85,39
|
-90,55
|
Nettowinst (verlies)
1 |
-44,26
|
-34,12
|
-68,76
|
-68,17
|
-74,73
|
-80,62
|
-85,59
|
Nettomarge
|
-
|
-110,1%
|
-440,29%
|
-744,17%
|
-1.067,52%
|
-746,47%
|
-578,28%
|
WPA
2 |
-16,02
|
-1,220
|
-1,900
|
-1,630
|
-1,548
|
-1,510
|
-1,474
|
Free Cash Flow
1 |
-
|
-62,01
|
-75,54
|
-
|
-82,44
|
-91,64
|
-97,04
|
FCF-marge
|
-
|
-200,14%
|
-483,67%
|
-
|
-1.177,67%
|
-848,56%
|
-655,64%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
05-03-21
|
17-03-22
|
14-03-23
|
12-03-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
3,746
|
20,22
|
3,384
|
0,382
|
6,402
|
5,45
|
5,313
|
2,004
|
1,185
|
0,659
|
2,333
|
2,333
|
2,333
|
2,333
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-14,52
|
2,792
|
-16,96
|
-20,95
|
-17,88
|
-15,11
|
-15,52
|
-18,49
|
-19,5
|
-21,91
|
-19,74
|
-19,31
|
-20,27
|
-20,45
|
-
|
Operationele Marge
|
-387,67%
|
13,81%
|
-501,24%
|
-5.484,55%
|
-279,23%
|
-277,32%
|
-292,02%
|
-922,65%
|
-1.645,82%
|
-3.324,43%
|
-846,19%
|
-827,43%
|
-868,9%
|
-876,52%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-14,52
|
2,797
|
-16,84
|
-20,49
|
-17,34
|
-14,1
|
-14,22
|
-17,12
|
-17,34
|
-19,65
|
-18,88
|
-18,46
|
-19,49
|
-19,76
|
-
|
Nettowinst (verlies)
1 |
-14,52
|
2,797
|
-16,84
|
-20,49
|
-17,34
|
-14,1
|
-14,22
|
-17,12
|
-17,34
|
-19,49
|
-18,88
|
-18,46
|
-19,49
|
-19,76
|
-15,55
|
Nettomarge
|
-387,48%
|
13,83%
|
-497,61%
|
-5.364,14%
|
-270,82%
|
-258,66%
|
-267,63%
|
-854,04%
|
-1.463,54%
|
-2.957,36%
|
-809,14%
|
-790,99%
|
-835,14%
|
-847%
|
-
|
WPA
2 |
-0,4000
|
0,2400
|
-0,4700
|
-0,5700
|
-0,4800
|
-0,3900
|
-0,3900
|
-0,4400
|
-0,4000
|
-0,4000
|
-0,4125
|
-0,3900
|
-0,3925
|
-0,3900
|
-0,3200
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10-11-21
|
17-03-22
|
12-05-22
|
11-08-22
|
07-11-22
|
14-03-23
|
15-05-23
|
10-08-23
|
09-11-23
|
12-03-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
232
|
157
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-62
|
-75,5
|
-
|
-82,4
|
-91,6
|
-97
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-63,9%
|
-38,8%
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
8,830
|
4,890
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-2,150
|
-2,050
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
1,76
|
1,43
|
-
|
1,94
|
1,8
|
1,49
|
Capex/omzet
|
-
|
5,68%
|
9,16%
|
-
|
27,71%
|
16,67%
|
10,03%
|
Datum van publicatie
|
05-03-21
|
17-03-22
|
14-03-23
|
12-03-24
|
-
|
-
|
-
|
Laatste slotkoers
1,3
USD Gemiddelde koersdoel
8,333
USD Spread / Gemiddelde doel +541,03% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -34,01% | 62,74 mln. | | +1,51% | 42,75 mld. | | +49,22% | 41,61 mld. | | +8,57% | 41,34 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|